2016 Diagnostic Cytopathology

Faculty

January 16, 2016 to January 18, 2016
Riviera Resort, Palm Springs, CA

2016 Diagnostic Cytopathology
Kristen Atkins, M.D.

Kristen Atkins, M.D.

Course Co-Director

Dr. Kristen Atkins is an associate professor of Pathology at the University of Virginia (UVA) with particular interests in women’s oncology and cytopathology. She entered academics primarily for teaching opportunities and was recently awarded the Master Educator Award for graduate medical education at UVA. She has given many workshops, teleconferences, and national meeting presentations on a variety of cytopathology topics and this is her second year directing this course. For the USCAP Diagnostic Cytopathology course she strives to bring together a dynamic group of faculty with different but complementary teaching styles to engage attendees. Dr. Atkins is interested in communication styles and personality traits, and often weaves these into her talks about challenges with preliminary interpretations and triaging tissue while interacting with various clinicians and staff. Outside of pathology she enjoys being with her family, reading novels (the quirkier the better), hiking in the Blue Ridge Mountains, and building with clay.

Güliz A. Barkan, M.D., FIAC

Güliz A. Barkan, M.D., FIAC

Dr. Güliz Barkan is a board certified Anatomic Pathologist and Cytopathologist, associate professor of Pathology and Urology, and currently the director of Cytology, the director of the Residency Program in Anatomic and Clinical Pathology, the director of the Cytopathology Fellowship Program and the vice chair of education at Loyola University Medical Center, Maywood, IL.

Dr. Barkan received her medical degree from Marmara University School of Medicine in Istanbul, Turkey in 1995. She completed residency in Anatomic and Clinical Pathology at The University of Michigan, Ann Arbor, Michigan in 2001. She finished a Surgical Pathology fellowship in the same institution in 2002 and a Cytopathology fellowship at the University of Texas M.D. Anderson Cancer Center, Houston, Texas in 2003. After a brief period in private practice in Turkey she joined Loyola University Department of Pathology in January 2006. Her interests include surgical pathology and cytopathology of the genitourinary tract, and pathology education. She has authored a number of peer- reviewed publications, abstracts, chapters, and given national and international invited talks and workshops mostly in the fields of cytopathology and surgical pathology of the genitourinary system. 

Dr. Barkan is serving as a member of the American Board of Pathology Test Committee, and a member of the Pathology Residency Program Directors Council. Actively involved with the American Society of Cytopathology, she is a member of the Executive Board and current chair of the Cyto-e conference Committee. She is also a fellow of the International Academy of Cytology.

Anna Berry, M.D.

Anna Berry, M.D.

Dr. Anna Berry is the director of Molecular Diagnostics at CellNetix Pathology and Laboratories and Symbiodx, and the scientific director of the Personalized Medicine Program at the Swedish Cancer Institute. She is a graduate of the University of Nebraska Medical Center, and completed her post-graduate training at SUNY Upstate Medical University, the Medical College of Virginia, and the National Cancer Institute. Dr. Berry is board certified in molecular genetic pathology, cytopathology, anatomic pathology and clinical pathology, and served previously as the director of Molecular Pathology and the director of the Molecular Genetic Pathology Fellowship Training Program at UCSF, where she retains an appointment as associate professor. Her clinical focus is making genomic technologies accessible to patients, and integrating genomic data into patient care. She serves on several national committees, including the Personalized Healthcare Committee of the College of American Pathologists, participates in several national genomics task forces and leads the Task Force for Genomics Education of Fellows for the Association for Molecular Pathology, and also represents the Association for Molecular Pathology at the Intersociety Coordinating Committee for Genomics Education at the NHGRI. Dr. Berry has given invited lectures and has taught CME courses at many locations across the country, as well as online.

Sara E. Monaco, M.D.

Sara E. Monaco, M.D.

Dr. Sara Monaco is an associate professor at the University of Pittsburgh Medical Center (UPMC) specializing in non-gynecological cytopathology. She is currently the Cytopathology Fellowship Program Director at UPMC, and is also the director of the Fine Needle Aspiration (FNA) Biopsy Services at Children’s Hospital of Pittsburgh of UPMC and UPMC-Shadyside Hospital. Her research interests include fine-needle aspiration (FNA) biopsy diagnoses, cytology-histology correlations, pediatric cytopathology, and the application of ancillary studies and molecular diagnostics in cytopathology. Dr. Monaco has presented several educational courses at national meetings, including the United Stated and Canadian Academy of Pathology (USCAP), American Society of Cytopathology (ASC), and the American Society of Clinical Pathologists (ASCP).  She is currently a co-chair for the ASC Website Committee, and a co-chair for the ASCP Case Reports in Cytopathology.  On a personal note, Dr. Monaco resides in Pittsburgh with her husband and three children.

Ritu Nayar, MBBS, M.D.

Ritu Nayar, MBBS, M.D.

Course Co-Director

Dr. Ritu Nayar is a professor of Pathology and director of Cytopathology at Northwestern University, Chicago. She is Immediate-Past President of the American Society of Cytopathology (ASC), a member of the Executive Council of the International Academy of Cytology (IAC) and in 2015 was elected as a Trustee for the American Board of Pathology (ABP).

Dr. Nayar’s clinical practice includes anatomic pathology, administration, teaching and translational research. She has published over 150 journal articles/book chapters and edited seven books. Her special interests include gynecologic and thyroid pathology and she is co-editor of the second and third editions of The Bethesda System for Reporting Cervical Cytology Atlases and a contributing author for The Bethesda System for Reporting Thyroid Cytopathology Atlas. Dr. Nayar has been actively involved in organized pathology for over 25 years, having chaired and served on several committees, in a number of major professional organizations, including the ASC, ASCP, ABP, CAP, USCAP, IAC and the NCI. She currently serves as section editor or editorial board member for eight pathology journals and is a frequent guest speaker and moderator at national and international pathology meetings.

Erik Ranheim, M.D., Ph.D.

Erik Ranheim, M.D., Ph.D.

Dr. Erik Ranheim M.D., Ph.D. received his B.A. in psychology from the University of Pennsylvania. He completed his M.D. and Ph.D. in immunology at the University of Minnesota and University of California, San Diego. As a graduate student, he studied how different receptors on the surface of normal and cancerous white blood cells interact during immune responses, and how these pathways might be used to generate immune responses against malignant cells. He did his clinical training in AP and hematopathology at Stanford University and was a post-doctoral fellow in the lab of Irving Weissman where he studied B cell development, stem cell biology, and anti-tumor immunity. He joined the faculty at the University of Wisconsin, Madison in 2003. Currently, Erik is professor and Vice Chair for Education in the Department of Pathology and Laboratory Medicine at UW where his research interests continue to be in B cell leukemogenesis and tumor immunology.

Meetings

home-circle-inset-1
view more